Purple Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PPBT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,377,0000.65%
Institutions2,640,3760.722%
Hedge Funds31,600,0008.64%
General Public329,251,24890%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.6%.


Top Shareholders

Top 15 shareholders own 10.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.64%
Armistice Capital LLC
31,600,000₪1.5m133%0.01%
0.44%
Morgan Stanley, Investment Banking and Brokerage Investments
1,611,000₪74.1k-20.6%no data
0.36%
Gil Efron
1,325,000₪60.9k0%no data
0.29%
Jason Carrick
1,052,000₪48.4k0%no data
0.2%
BNP Paribas Arbitrage Sa, Asset Management Arm
735,000₪33.8k0%no data
0.027%
Meitav Investment House Ltd
98,392₪4.5k0%no data
0.014%
Tower Research Capital Europe Limited
50,800₪2.3k0%no data
0.013%
Psagot Index Funds Ltd
46,927₪2.2k0%no data
0.011%
Toronto-Dominion Bank, Banking Investments
40,000₪1.8k0%no data
0.0059%
RBC Dominion Securities Inc., Asset Management Arm
21,400₪984.60%no data
0.005%
Harel Insurance Investments and Finances Services Ltd, Asset Management Arm
18,257₪839.80%no data
0.0023%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
8,400₪387.10%no data
0.0011%
Group One Trading LP, Asset Management Arm
4,000₪183.40%no data
0.00087%
Global Retirement Partners, LLC
3,200₪146.40%no data
0.00082%
North Star Investment Management Corporation
3,000₪138.00%no data